T1	Participants 273 341	patients affected by cervical cancer undergoing radical hysterectomy
T2	Participants 351 464	Consecutive patients affected by stage IB-IIB cervical carcinoma scheduled for radical surgery entered the study.
T3	Participants 591 645	All patients underwent classical radical hysterectomy.
T4	Participants 772 803	168 patients entered the study.
